Boston Scientific Corporation (BVMF:B1SX34)
Brazil
· Delayed Price · Currency is BRL 520.86
-9.70 (-1.83%)
At close: Dec 3, 2025
Revenue
Fiscal year is January - December.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2013 - 2020 |
|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2013 - 2020 |
| MedSurg Revenue | 6.63B | 5.99B |
Log In |
Log In |
Log In | Upgrade
|
| Cardiovascular Revenue | 12.72B | 10.76B |
Log In |
Log In |
Log In | Upgrade
|
| Other Segment Revenue | - | - |
Log In |
Log In |
Log In | Upgrade
|
| Revenue (Other) | 1.00M | -1.00M |
Log In |
Log In |
Log In | Upgrade
|
| Revenue (Total) | 19.35B | 16.75B |
Log In |
Log In |
Log In | Upgrade
|
| Other Segment Revenue | - | - |
Log In |
Log In |
Log In | Upgrade
|
Revenue by Geography
Fiscal year is January - December.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2013 - 2020 |
|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2013 - 2020 |
| Other Segment Revenue | - | - |
Log In |
Log In |
Log In | Upgrade
|
| Other Segment Revenue | - | - |
Log In |
Log In |
Log In | Upgrade
|
| U.S Revenue | 12.37B | 10.21B |
Log In |
Log In |
Log In | Upgrade
|
| Europe, Middle East and Africa Revenue | 3.35B | 3.23B |
Log In |
Log In |
Log In | Upgrade
|
| Asia-Pacific Revenue | 2.98B | 2.69B |
Log In |
Log In |
Log In | Upgrade
|
| Latin America and Canada Revenue | 654.00M | 624.00M |
Log In |
Log In |
Log In | Upgrade
|
| Revenue (Other) | 1.00M | -1.00M |
Log In |
Log In |
Log In | Upgrade
|
| Revenue (Total) | 19.35B | 16.75B |
Log In |
Log In |
Log In | Upgrade
|
EBT
Fiscal year is January - December.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2012 - 2019 |
|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2012 - 2019 |
| MedSurg Income Before Taxes | - |
Log In |
Log In |
Log In | Upgrade
|
| Cardiovascular Income Before Taxes | - |
Log In |
Log In |
Log In | Upgrade
|
Key Performance Indicators
Fiscal year is January - December.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2012 - 2019 |
|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2012 - 2019 |
| MedSurg Organic Revenue Growth | 7.50% |
Log In |
Log In |
Log In | Upgrade
|
| Rhythm & Neuro Organic Revenue Growth | - |
Log In |
Log In |
Log In | Upgrade
|
| Cardiovascular Organic Revenue Growth | 21.90% |
Log In |
Log In |
Log In | Upgrade
|
| Total Organic Revenue Growth | 16.40% |
Log In |
Log In |
Log In | Upgrade
|